1-(Bromomethyl)-4-butylbenzene

Catalog No. :
ACKZXY021
CAS No. :
10531-16-5
Molecular Formula :
C11H15Br
Molecular Weight :
227.15

IUPAC Name:1-(bromomethyl)-4-butylbenzene

1-(Bromomethyl)-4-butylbenzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$51.00Login to see priceIn stockInquiry
5g98%$185.00Login to see priceIn stockIn stock
10g98%$329.00Login to see priceIn stockIn stock
25g98%$659.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Bromomethyl)-4-butylbenzene
IUPAC Name1-(bromomethyl)-4-butylbenzene
MDL No.MFCD09038507
Molecular FormulaC11H15Br
Molecular Weight227.15
SMILESCCCCC1=CC=C(CBr)C=C1
InChI KeyXNQBGVFFKGZXJH-UHFFFAOYSA-N
Synonym4-BUTYLBENZYL BROMIDE;Benzene, 1-(bromomethyl)-4-butyl-;1-broMoMethyl-4-butyl-benzene;4-Butylbenzyl Bromide &gt
CAS No.10531-16-5
PubChem CID12150840

Safety Data

Pictogram
Corrosive
Signal Word
Gefahr
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACKZXY021 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0 In Stock
  2. Plus
  3. ACTNWM139 route compound structure diagram
    ACTNWM13960834-63-1 In Stock
  4. Then
  5. ACKZXY021 route product structure diagram
    ACKZXY02110531-16-5 In Stock
Inquiry

2. ACKZXY021 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDN037 route compound structure diagram
    ACJSDN0377789-46-0 In Stock
  2. Plus
  3. ACTNWM139 route compound structure diagram
    ACTNWM13960834-63-1 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACKZXY021 route product structure diagram
    ACKZXY02110531-16-5 In Stock
Inquiry

Comments (0)